期刊文献+

ESC/ERS《肺动脉高压诊断和治疗指南》解读之定义与分类 被引量:18

原文传递
导出
摘要 随着人们认识的深入,肺动脉高压的定义与分类也在不断更新。本文就2015年欧洲心脏病学会/欧洲呼吸学会(ESC/ERS)《肺动脉高压诊断和治疗指南》中有关的定义与分类更新进行解读,并结合临床实际应用对指南的变化加以阐述。
出处 《中华医学杂志》 CAS CSCD 北大核心 2016年第10期827-829,共3页 National Medical Journal of China
基金 国家自然科学基金(81570049) 北京市自然科学基金(7152062) 卫生部公益性行业科研专项(201302008) 北京市卫生系统高层次卫生技术人才培养计划(2013.6-2016.6)
  • 相关文献

参考文献8

  • 1Gali N, Humbert M, Vachiery J, et al. 2015 ESC/ERSGuidelines for the diagnosis and treatment of pulmonary hypertension[ J]. Eur Respir J, 2015, 46 (4) : 903-975. DOI: 10. 1093/eurheartj/ehv317.
  • 2Kovacs G, Berghold A, Scheidl S, et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review[J]. Eur Respir J, 2009, 34(4): 888-894. DOI: 10. 1183/09031936. 00145608.
  • 3Badesch DB, Champion HC, Gomez Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension[J]. J Am Coll Cardio, 2009, 54(1) : $55-$66. DOI: 10. 1016/jacc. 2009. 04. 011.
  • 4Yang T, Li X, Qin J, et al. High altitude-induced borderline pulmonary hypertension impaired cardiorespiratory fitness in healthy young men [ J] . Int J Cardiol, 2015, 181 : 382-388. DOI: 10. 1016/j. ijcard. 2014. 12. 044.
  • 5Vachi6ry J, Adir Y, Barber JA, et al. Pulmonary hypertension due to left heart diseases[J]. J Am Coll Cardio, 2013, 62(25) : D100-DI08. DOI:10. 1016/j. jacc. 2013. 10. 033.
  • 6Naeije R, Vachiery JL, Yerly P, et al. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease [J]. Eur Respir J, 2012, 41 ( 1 ) : 217-223. DOI: 10. 1183/ 09031936. 00074312.
  • 7Gerges C, Gerges M, Lang MB, et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in " Out-of- Proportion" pulmonary hypertension[ J]. Chest, 2013, 3 ( 143 ) : 758-766. DOI:IO. 1378/chest. 12-1653.
  • 8熊长明.肺动脉高压诊治中值得注意的几个问题[J].中华医学杂志,2013,93(40):3172-3174. 被引量:7

二级参考文献18

  • 1胡盛寿,朱晓东,郭加强,吴学军,薛淦兴.先天性心脏病合并重度肺动脉高压的临床分级再讨论──314例远期疗效的随访研究[J].中国循环杂志,1995,10(3):151-154. 被引量:36
  • 2Aronson JK. Rare diseases and orphan drugs. Br J Clin Pharmacol, 2006, 61: 243-245.
  • 3Galio N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension : the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J, 2009, 30:2493-2537.
  • 4D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med, 1991, 115:343-349.
  • 5Oya H, Nagaya N, Uematsu M, et al. Poor prognosis and related factors in adults with Eisenmenger syndrome. Am Heart J, 2002, 143 : 739-744.
  • 6Cantor WJ, Harrison DA, Moussadji JS, et al. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol, 1999, 84: 677-681.
  • 7Zeng WJ, Sun Y J, Gu Q, et al. The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension. Pu|m Circ, 2012, 2: 373-378.
  • 8Benza RL, Miller DP, Barst RJ, et al. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest, 2012, 142: 448456.
  • 9Hoeper MM, Lee SH, Voswincke R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coil Cardiol, 2006, 48 : 2546-2552.
  • 10Tuder RM, Abman SH, Braun T, et al. Development and pathology of pulmonary hypertension. J Am Coil Cardiol, 2009, 54 (1 Suppl) : S3-S9.

共引文献6

同被引文献208

引证文献18

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部